News / Taiwan / economic_daily
Taiwan Biotech Sector Hits Record Market Cap of NT$1.7 Trillion
Health Technology · Biotechnology · economic_daily · 2026-10-04
Taiwan's biotech sector reached a record market capitalization of NT$1.77 trillion by the end of September, with 159 listed companies showing strong growth.
What Happened
Sector Expansion: The Taiwanese biotechnology and medical industry continues to expand its footprint in the capital market. According to the latest statistics from PwC, the number of listed companies in this sector has reached 159 as of September 30.
Record Valuation: The total market capitalization of these biotech and medical stocks has climbed to NT$1.77 trillion. This represents an increase of NT$214.17 billion compared to the end of 2025, setting a new historical milestone.
Market Momentum: The growth in market value highlights the robust momentum within the biotech sector, reflecting both an increase in the number of listed firms and higher overall valuations. Investors continue to show strong confidence in the long-term prospects of the healthcare industry.
Year-End Outlook: Given the current trajectory and ongoing industrial innovation, market observers remain optimistic about the sector's performance. It is anticipated that the biotech and medical segment will continue to deliver strong results through the end of the year.